# OnCo record nct06340568 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06340568/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06340568", "NCT06340568" ;
  schema:name "A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer"@en ;
  schema:alternateName "Fern-EC-01"@en ;
  schema:description "A phase 3 trial of Trastuzumab pamirtecan, Doxorubicin, Paclitaxel / nab-paclitaxel in endometrial cancer, run by BioNTech SE, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06340568/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06340568> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-06-10" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-pamirtecan/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/docetaxel/> ;
  onco:companies <https://onco.cc/companies/biontech/> .